Medicus Pharma Ltd Stock Number Of Shares Shorted
| MDCX Stock | USD 2.99 0.47 18.65% |
Medicus Pharma Ltd fundamentals help investors to digest information that contributes to Medicus Pharma's financial success or failures. It also enables traders to predict the movement of Medicus OTC BB Equity. The fundamental analysis module provides a way to measure Medicus Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicus Pharma otc bb equity.
Medicus | Number Of Shares Shorted |
Medicus Pharma Ltd Company Number Of Shares Shorted Analysis
Medicus Pharma's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Medicus Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for Medicus Pharma is extremely important. It helps to project a fair market value of Medicus OTC BB Equity properly, considering its historical fundamentals such as Number Of Shares Shorted. Since Medicus Pharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medicus Pharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medicus Pharma's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Medicus Pharma Ltd has 0.0 of outstending shares currently sold short by investors. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Medicus Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medicus Pharma's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the otc bb equitys which would be a good addition to a portfolio. Peer analysis of Medicus Pharma could also be used in its relative valuation, which is a method of valuing Medicus Pharma by comparing valuation metrics of similar companies.Medicus Pharma is currently under evaluation in number of shares shorted category among its peers.
Medicus Fundamentals
| Current Valuation | 27.79 M | ||||
| Price To Earning | (0.21) X | ||||
| Price To Book | 10.12 X | ||||
| EBITDA | (323.24 K) | ||||
| Net Income | (6.78 M) | ||||
| Cash And Equivalents | 1.22 K | ||||
| Total Debt | 1.09 M | ||||
| Current Ratio | 0.53 X | ||||
| Book Value Per Share | (0.13) X | ||||
| Cash Flow From Operations | (4.16 M) | ||||
| Target Price | 7.81 | ||||
| Number Of Employees | 15 | ||||
| Beta | 5.96 | ||||
| Market Capitalization | 36.08 M | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (19.18 M) | ||||
| Working Capital | 805.8 K | ||||
| Net Asset | 1.89 M |
About Medicus Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicus Pharma Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicus Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicus Pharma Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.